Market Research Logo

Global Biologics Outsourcing Services Market: Size, Trends & Forecasts (2017-2021)

Global Biologics Outsourcing Services Market: Size, Trends & Forecasts (2017-2021)

Scope of the Report

The report entitled “Global Biologics Outsourcing Services Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global biologics outsourcing services market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis includes the market by value, by R&D spending and by segmentation.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics outsourcing services market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Wuxi Biologics, Lonza, Patheon and Boehringer Ingelheim are some of the key players operating in the global biologics outsourcing services market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

Wuxi Biologics
Lonza
Patheon
Boehringer Ingelheim

Executive Summary

Pharma industry complies with the development and production of varied types of drugs and medicines for diagnosis, cure, treatment or prevention of disease. Pharmaceutical drugs are classified on many basis such as analgesics, antimalarial, antibiotics, mood stabilizers, hormone replacements, stimulants, tranquilizers, etc.

Usually all the pharmaceutical medicines can be segmented biologics and non-biologics. Biologics are those medicines which are manufactured with a living cell such as microorganism and composed of complex combination of substances like sugar, proteins, etc. Biologics are mainly used in the treatment of number of chronic diseases (cancer, diabetes, blood pressure, etc.). Biologics are of many types based on their source of development: blood component, blood, tissues, cells, vaccines, allergens. Biologics also consist of of many side effects.

Biologics outsourcing is defined as outsourcing of various biologics services. Four steps in biologics outsourcing value chain are: discovery, preclinical development, clinical development and commercialization. Biologics service outsourcing provides many advantages such as flexible and convenient method for research and development of drugs, reduction in capital investment, etc. The global biologics outsourcing services market is expected to increase at high growth rates during the forecasted period (2017-2021).

The global biologics outsourcing services market is supported by various growth drivers, such as growing demand for outsourcing variety, demand of antibody conjugate, increasing biologics approvals, etc. Yet, the market faces certain challenges, such as, lack of knowledge in biopharma industry, complexities in handling biologics, etc. Few new market trends are also provided such as, outsourcing of clinical trials, demand for contract research organization and contract manufacturing organization, growing bio-analytical testing demand, etc.


1. Executive Summary
2. Introduction
2.1 Pharmaceutical Drug: An Overview
2.1.1 Pharmaceutical Drugs Meaning
2.1.2 Classification of Pharmaceutical Drugs
Table 1: Classification of Pharmaceutical Drugs
2.1.3 Types of Pharmaceutical Medicines
Table 2: Types of Pharmaceutical Drugs
2.1.4 Segments of Pharmaceutical Medicines
Table 3: Segments of Pharmaceutical Medicines
2.2 Biologics : An Overview
2.2.1 Biologics Definition
2.2.2 Biologics Medical Uses
2.2.3 Types of Biologics Products
Table 4: Types of Biologics Products
2.2.4 Side Effects of Biologics
Table 5: Side Effects of Biologics
2.2.5 Biologics Outsourcing
2.2.6 Biologics Outsourcing Value Chain
Table 6: Biologics Outsourcing Value Chain
2.2.7 Advantages of Biologics Outsourcing
Table 7: Advantages of Biologics Outsourcing
3. Global Market Analysis
3.1 Global Pharmaceutical Market: An Analysis
3.1.1 Global Pharmaceutical Market by Value
Table 8: Global Pharmaceutical Market by Value; 2011-2016 (US$ Billion)
Table 9: Global Pharmaceutical Market by Value; 2017-2021 (US$ Billion)
3.1.2 Global Pharmaceutical Market by Segment
Table 10: Global Pharmaceutical Market by Segment; 2016 (Percentage, %)
3.1.3 Global Non-Biologics Market by Value
Table 11: Global Non-Biologics Market by Value; 2011-2016 (US$ Billion)
Table 12: Global Non-Biologics Market by Value; 2017-2021 (US$ Billion)
3.2 Global Biologics Market: An Analysis
3.2.1 Global Biologics Market by Value
Table 13: Global Biologics Market by Value; 2011-2016 (US$ Billion)
Table 14: Global Biologics Market by Value; 2017-2021 (US$ Billion)
3.2.2 R&D Spending on Biologics Market by Value
Table 15: R&D Spending on Biologics Market by Value; 2015-2021 (US$ Billion)
3.2.3 Global Biologics Outsourcing Services Market by Value
Table 16: Global Biologics Outsourcing Services Market by Value; 2011-2016 (US$ Billion)
Table 17: Global Biologics Outsourcing Services Market by Value; 2017-2021 (US$ Billion)
3.2.4 Global Biologics Outsourcing Services by Penetration
Table 18: Global Biologics Outsourcing Services by Penetration; 2016 (Percentage, %)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Research and Development Funding
4.1.2 Growing Demand for Outsourcing Variety
4.1.3 Innovative Treatment for Previously Untreatable Diseases
4.1.4 Demand of Antibody Conjugate
4.1.5 Bounce in Company Collaboration
Table 19: Top Collaborations in Pharmaceutical Companies; 2015-2016
4.1.6 Increasing Biologics Approvals
Table 20: FDA Approved Medicines; 2010-2015
4.1.7 Raising Autoimmune Disease Prevalence
Table 21: Prevalence of Diagnosed Autoimmune Conditions; 2016
4.1.8 Favorable States in China
4.1.9 Flexible and Customizable CMO Market
4.1.10 Increasing Household Disposable Income
Table 22: The Global GNI Per Capita; 2011-2015 (US$)
4.1.11 Emergence and Approval of Affordable Biosimilars
Table 23: New Approved Biosimilars; 2015-2017
4.2 Challenges
4.2.1 Lack of Knowledge in Biopharma Industry
4.2.2 Time Consuming and Capital Intensive Investment
4.2.3 Complexities in Handling Biologics
4.2.4 Costly Drug Development Process
4.2.5 Conflict of Interest Between Companies
4.3 Market Trends
4.3.1 Suppliers With Technical Competence
4.3.2 Outsourcing of Clinical Trials
4.3.3 Growing Bio-analytical Testing Demand
4.3.4 Demand for Contract Research Organization and Contract Manufacturing Organization
5. Competitive Landscape
5.1 Biologics Service Outsourcing Market by Players
5.1.1 Biologics Outsourcing Services Market Share by Player
Table 24: Biologics Outsourcing Services Market Share by Player; 2015 (Percentage, %)
5.1.2 Biologics Service Outsourcing Market Players by Service Spectrum
Table 25: Biologics Service Outsourcing Market Players by Service Spectrum; 2017
6. Company Profiling
6.1 Wuxi Biologics
6.1.1 Business Overview
6.1.2 Financial Overview
Table 26: Wuxi Biologics Revenue; 2014-2016 (US$ Million)
Table 27: Wuxi Biologics Revenue by Region; 2016 (Percentage, %)
6.1.3 Business Strategy
6.2 Lonza
6.2.1 Business Overview
6.2.2 Financial Overview
Table 28: Lonza Sales; 2012-2016 (US$ Billion)
Table 29: Lonza Sales by Segment; 2016 (Percentage, %)
Table 30: Lonza Sales by Region; 2016 (Percentage, %)
6.2.3 Business Strategy
6.3 Boehringer Ingelheim
6.3.1 Business Overview
6.3.2 Financial Overview
Table 31: Boehringer Ingelheim Net Sales; 2013-2016 (US$ Billion)
Table 32: Boehringer Ingelheim Net Sales by Segment; 2016 (Percentage, %)
Table 33: Boehringer Ingelheim Net Sales by Region ; 2016 (Percentage, %)
6.3.3 Business Strategy
6.4 Patheon Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
Table 34: Patheon Revenue; 2012-2016 (US$ Million)
Table 35: Patheon Revenue by Segments; 2016 (Percentage, %)
6.4.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report